血栓通聯(lián)合依達拉奉治療急性腦梗死患者的效果及其神經(jīng)功能、實驗室指標(biāo)分析

打開文本圖片集

【摘要】目的：分析血栓通聯(lián)合依達拉奉治療急性腦梗死患者的效果及其神經(jīng)功能、實驗室指標(biāo)。方法：2019年9月—2021年8月，從本院收治的急性腦梗死患者中選取130例，按照選取順序編號，抽簽分兩組，各65例，對照組實施依達拉奉治療，試驗組實施血栓通聯(lián)合依達拉奉治療，比較兩組治療效果。結(jié)果：試驗組治療總有效率為96.93%，高于對照組86.15%（P0.05）；治療后兩組NIHSS評分、IL-6、TNF-α水平均低于治療前（P

【關(guān)鍵詞】急性腦梗死；血栓通；依達拉奉；神經(jīng)功能；實驗室指標(biāo)

Effect of Xueshuantong and edaravone in the treatment of patients with acute cerebral infarction and analysis of its neurological function and laboratory indexes

LI Jian， DONG Jing

Xixiang County People’s Hospital， Hanzhong， Shaanxi， 723500， China

【Abstract】Objective： To analyze the effect of Xueshuantong and edaravone in the treatment of patients with acute cerebral infarction and its neurological function and laboratory indicators. Methods： From September 2019 to August 2021， 130 patients with acute cerebral infarction admitted to our hospital were selected. Numbered according to the order of selection， and divided into two groups by lottery， each with 65 cases. The control group was treated with edaravone， and the experimental group was treated with Xueshuantong and edaravone. The treatment effects of the two groups were compared. Results： The total effective rate of the experimental group was 96.93%， which was higher than that of the control group， 86.15%（P0.05）. After treatment， the NIHSS scores， IL-6， and TNF-α levels in the two groups were lower than those before treatment（P

【Key words】acute cerebral infarction； Xueshuantong； edaravone； neurological function； laboratory indicators

急性腦梗死是常見腦血管疾病，具體發(fā)病與血栓形成、腦組織缺氧缺血有關(guān)，目前我國居民飲食結(jié)構(gòu)、生活方式不斷發(fā)生變化，且生活節(jié)奏加快，導(dǎo)致此疾病發(fā)病率呈上升趨勢，而急性腦梗死患者伴有明顯神經(jīng)功能缺損問題，死亡率較高，嚴(yán)重威脅患者生命安全[1-2]。（剩余3473字）